Logo image
Brevetoxin-2, is a unique inhibitor of the C-terminal redox center of mammalian thioredoxin reductase-1
Journal article   Open access   Peer reviewed

Brevetoxin-2, is a unique inhibitor of the C-terminal redox center of mammalian thioredoxin reductase-1

Wei Chen, Anupama Tuladhar, Shantelle Rolle, Yanhao Lai, Freddy Rodriguez del Rey, Cristian E. Zavala, Yuan Liu and Kathleen S. Rein
Toxicology and applied pharmacology, Vol.329, pp.58-66
08-15-2017
PMCID: PMC5623065
PMID: 28551108

Abstract

Life Sciences & Biomedicine Pharmacology & Pharmacy Science & Technology Toxicology
Karenia brevis, the Florida red tide dinoflagellate produces a suite of neurotoxins known as the brevetoxins. The most abundant of the brevetoxins PbTx-2, was found to inhibit the thioredoxin-thioredoxin reductase system, whereas the PbTx-3 has no effect on this system. On the other hand, PbTx-2 activates the reduction of small disulfides such as 5,5'-dithio-bis-(2-nitrobenzoic acid) by thioredoxin reductase. PbTx-2 has an alpha,beta-unsaturated aldehyde moiety which functions as an efficient electrophile and selenocysteine conjugates are readily formed. PbTx-2 blocks the inhibition of TrxR by the inhibitor curcumin, whereas curcumin blocks PbTx-2 activation of TrxR. It is proposed that the mechanism of inhibition of thioredoxin reduction is via the formation of a Michael adduct between selenocysteine and the alpha,beta-unsaturated aldehyde moiety of PbTx-2. PbTx-2 had no effect on the rates of reactions catalyzed by related enzymes such as glutathione reductase, glutathione peroxidase or glutaredoxin. (C) 2017 Elsevier Inc. All rights reserved.
url
https://www.ncbi.nlm.nih.gov/pmc/articles/5623065View
Open

Related links

Metrics

Details

Logo image